CardioFocus, Inc.

CardioFocus is a medical device innovator and manufacturer dedicated to advancing ablation treatment for cardiac disorders such as atrial fibrillation (AFib), the most common heart arrhythmia.  The company’s FDA-approved HeartLight Endoscopic Ablation System has successfully treated more than 9,000 patients in the United States, Europe and Japan. The HeartLight System is a revolutionary catheter ablation technology that along with direct visualization and titratable laser energy, represents a new standard for AFib ablation. CardioFocus is headquartered in Marlborough, MA. For more information, visit www.CardioFocus.com.

In the US, HeartLight X3 is indicated for the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation.